Swissmedic has launched a public consultation on the Good Clinical Practice (GCP) Guideline E6(R3) of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human use (ICH). Stakeholders in Switzerland have the until 26 September 2023 to comment on the draft of ICH Guideline E6(R3).